New Product In-Licensing Analysis

 Do you understand the current reimbursement "space" in which the in-licensing candidate will be marketed?

A new drug or device that your company is considering for in-licensing may have clear clinical merits, but understanding the reimbursement environment is another key to a successful product. We analyze the various factors affecting coverage, coding and payment within the new product's target markets and help you gain a perspective on the challenges and opportunities that would affect ongoing product development and ultimate commercialization.